Impact of Androgen Deprivation Therapy Associated to Conformal Radiotherapy in the Treatment of D’Amico Intermediate-/High-Risk Prostate Cancer in Older Patients

SIMPLE SUMMARY: Androgen Deprivation Therapy (ADT) combined with radiotherapy is recommended for a duration of 6 months in unfavorable D’Amico intermediate-risk (IR) prostate cancer and a duration of 18 to 36 months in D’Amico high-risk (HR) prostate cancer. However, as patients ≥80 years are exclud...

Descripción completa

Detalles Bibliográficos
Autores principales: Couderc, Anne-Laure, Nicolas, Emanuel, Boissier, Romain, Boucekine, Mohammed, Bastide, Cyrille, Badinand, Delphine, Rossi, Dominique, Mugnier, Benedicte, Villani, Patrick, Karsenty, Gilles, Cowen, Didier, Lechevallier, Eric, Muracciole, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795189/
https://www.ncbi.nlm.nih.gov/pubmed/33383957
http://dx.doi.org/10.3390/cancers13010075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795189/
https://www.ncbi.nlm.nih.gov/pubmed/33383957
http://dx.doi.org/10.3390/cancers13010075

Ejemplares similares